DHR vs PATH · P/E 39, rev $24.57B vs P/E 19, rev $1.61B
Danaher Corporation (DHR) versus Uipath Inc (PATH) — a side-by-side from cached financials, not a winner call.
Danaher Corporation (DHR) is a diagnostics & research company listed on US.
Uipath Inc (PATH) is a software - infrastructure company listed on US.
Latest reported DHR revenue for 2025-12-31 was $24.57B. Net income was $3.61B. Revenue was up 2.9% from 2024-12-31 to 2025-12-31. DHR currently screens at market cap $144.18B and trailing P/E 39.0.
Latest reported PATH revenue for 2026-01-31 was $1.61B. Net income was $282.3M. Revenue was up 12.7% from 2025-01-31 to 2026-01-31. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
DHR currently screens at market cap $144.18B and trailing P/E 39.0. PATH currently screens at market cap $6.07B and trailing P/E 19.4.
Not investment advice. Open the DHR and PATH stock pages for the full models.
Not investment advice.